KPI Therapeutics, Inc. — Form D
KPI Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-05. The offering totals $3.0M, of which $18K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-12-05
- Form: D
- Accession: 0001607700-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $18K
- Remaining: $3.0M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2016-12-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275603
Issuer
- Name: KPI Therapeutics, Inc.
- CIK: 0001607700
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 401 TERRY AVENUE NORTH, 4TH FLOOR, SEATTLE, WA, 98109-5208
- Phone: 206-378-0400
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Ray E Bartoszek | Director | Seattle, WA |
| Shawn E Iadonato | Director | Seattle, WA |
| Charles L Magness | Director | Seattle, WA |
| Don E Merlino | Director | Seattle, WA |
| Steven E Mitchel | Director | Seattle, WA |
| James G. W. E Reed | Director | Seattle, WA |
| Paul E Sylvester | Director | Seattle, WA |
| Thomas E Hornish | Executive Officer | Seattle, WA |
| Charles L Magness | Executive Officer | Seattle, WA |
| Craig E Philips | Executive Officer | Seattle, WA |
| Don L Merlino | Director | Seattle, WA |
| James G. W. L Reed | Director | Seattle, WA |
| Craig L Philips | Executive Officer | Seattle, WA |
| Blake L Ilstrup | Executive Officer | Seattle, WA |
| Paul L Sylvester | Director | Seattle, WA |
| Magness L Charles | Director | Seattle, WA |
| Magness L Charles | Executive Officer | Seattle, WA |
Other filings by this issuer (3)
More